Randomised phase III trial of concurrent chemoradiotherapy with extended nodal irradiation and erlotinib in patients with inoperable oesophageal squamous cell cancer.
Wu SX, Wang LH, Luo HL, Xie CY, Zhang XB, Hu W, Zheng AP, Li DJ, Zhang HY, Xie CH, Lian XL, Du DX, Chen M, Bian XH, Tan BX, Jiang H, Zhang HB, Wang JH, Jing Z, Xia B, Zhang N, Zhang P, Li WF, Zhao FJ, Tian ZF, Liu H, Huang KW, Hu J, Xie RF, Du L, Li G.
Wu SX, et al. Among authors: zhang n, zhang xb, zhang hb, zhang p, zhang hy.
Eur J Cancer. 2018 Apr;93:99-107. doi: 10.1016/j.ejca.2018.01.085. Epub 2018 Mar 20.
Eur J Cancer. 2018.
PMID: 29494818
Clinical Trial.